Medpace Holdings, Inc. Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
Medpace Holdings, Inc. (MEDP) reported Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations of $1.41 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations · last filed 2026-02-10
- Medpace Holdings, Inc. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2025 was $1.41M, a 26.44% decline from fiscal 2024.
- Medpace Holdings, Inc. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2024 was $1.92M, a 125.47% increase from fiscal 2023.
- Medpace Holdings, Inc. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2023 was $852.00K, a 64.34% decline from fiscal 2022.
- Medpace Holdings, Inc. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2022 was $2.39M, a 130.82% increase from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 9 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month |
|---|---|---|
| 2025-12-31 | $1.41M 10-K · filed 2026-02-10 | |
| 2024-12-31 | $1.92M 10-K · filed 2026-02-10 | |
| 2023-12-31 | $852.00K 10-K · filed 2026-02-10 | |
| 2022-12-31 | $2.39M 10-K · filed 2025-02-11 | |
| 2021-12-31 | $1.03M 10-K · filed 2024-02-13 | |
| 2020-12-31 | $1.73M 10-K · filed 2023-02-14 | |
| 2019-12-31 | $0.00 10-K · filed 2022-02-15 | |
| 2018-12-31 | $0.00 10-K · filed 2021-02-16 | |
| 2017-12-31 | $0.00 10-K · filed 2020-02-25 | |
| 2016-12-31 | $75.00K 10-K · filed 2019-02-26 | |
| 2015-12-31 | $0.00 10-K · filed 2018-02-27 | |
| 2014-12-31 | $0.00 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |